C16NTD

General Information


DRACP ID  DRACP05611

Peptide Name   C16NTD

Sequence  XGLFGXGRKKRRQRRRPPQ

Sequence Length  19

UniProt ID  Not available

PubChem CID  Not available

Origin  Protein derived

Type  Native peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  X(1)=Doxorubicin; X(6)=(C16)Cys, Cys-Palmitoylation

Chiral  L



Physicochemical Information


Formula  C89H153N39O18

Absent amino acids  ACDEHIMNSTVWY

Common amino acids  R

Mass  259866

Pl  13.2

Basic residues  8

Acidic residues  0

Hydrophobic residues  2

Net charge  8

Boman Index  -10098

Hydrophobicity  -208.42

Aliphatic Index  20.53

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 24892976

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  2481

DRACP is developed by Dr.Zheng's team.